Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Large prostates link to more hair loss.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Seven new genetic risk areas for prostate cancer were found.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

A young dog with an enlarged prostate and cysts improved significantly after treatment and surgery.

Androgen receptors help prostate cancer cells grow and resist drugs.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Finasteride significantly reduces prostate cancer risk.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Hair loss can be an early sign of prostate enlargement.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.